Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117225) titled 'Impact of MET Gene Abnormalities on the Efficacy of Anti-HER2 Targeted Therapy in Chinese Gastric Cancer Patients: A Multicenter, Retrospective Cohort Study' on Jan. 21.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai East Hospital
Condition:
Gastric cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Observation group for gastric cancer treatment:420;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=290383
Disclaimer: Curated by HT Syndication....